OPR - Delayed Quote • USD SLGL May 2024 2.500 put (SLGL240517P00002500) Follow 1.4500 0.0000 (0.00%) As of January 11 at 9:30 AM EST. Market Open. Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for SLGL240517P00002500 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: SLGL Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream Sol-Gel Technologies Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments Sol-Gel Technologies Screens First Patient for SGT-610 Phase 3 Study Sol-Gel Technologies Ltd to Host Virtual KOL Event on Gorlin Syndrome and the Upcoming Phase 3 Trial for SGT-610 Is Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Trading At A 24% Discount? Sol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Update Zacks Industry Outlook Highlights Dr. Reddy's Laboratories, Amphastar Pharmaceuticals and Sol-Gel Technologies 3 Generic Drug Stocks to Watch Amid Improving Market Prospects Is Sol-Gel Technologies (NASDAQ:SLGL) In A Good Position To Invest In Growth? Sol-Gel Technologies to Participate in the H.C. Wainwright 25th Annual Global Investment Conference Sol-Gel Technologies Ltd. (SLGL) Reports Q2 Loss, Lags Revenue Estimates
